Fecal Incontinence, Neurogenic Bladder, Neurogenic Bowel, Overactive Bladder, Retention, Urinary, Urge Incontinence
Conditions
Keywords
Sacral Neuromodulation, Neurogenic Bladder, Neurogenic Bowel
Brief summary
The goal of this observational study is to evaluate efficacy and safety of sacral neuromodulation in neurogenic patients compared to non-neurogenic (idiopathic) patients. \[. The main question\[s\] it aims to answer are: * determine efficacy and safety of the therapy in neurogenic patients. * compare outcomes of the therapy to idiopathic patients. If there is a comparison group: Researchers will compare the outcomes of the therapy between the neurogenic and non-neurogenic subset of patients.
Interventions
DEVICEInterStim II
Sacral neuromodulation
Sponsors
Omri Schwarztuch Gildor
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Patients who underwent InterStim II advanced evaluation for approved indication
Exclusion criteria
* N/A
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease of at least 50% in number of urge urinary incontinence episodes | 1 year |
| Decrease of at least 50% in number of catheterizations per day | 1 year |
| Decrease of at least 50% in number of fecal incontinence episodes | 1 year |
Secondary
| Measure | Time frame |
|---|---|
| Number of revision surgeries | 1 year |
| number of follow-up visits for programming and/or troubleshooting | 1 year |
Countries
Israel
Outcome results
None listed